Paclitaxel/Ramucirumab vs. Paclitaxel in 2nd-line therapy of advanced esophageal squamous cell carcinoma: Randomized Phase II IKF-AIO-RAMOS Trial

2024-9-9

Combination therapy consisting of transarterial chemoembolization, lenvatinib, and programmed cell death protein 1 blockade for hepatocellular carcinoma with inferior vena cava tumor thrombus: a case series study and literature review

2024-8-7

Extraskeletal Ewing sarcoma of the extremities and trunk: a retrospective analysis of a mono-institutional series

2024-7-31

Female Patients with Small Cell Lung Cancer Have Better Survival than Males with Extensive but Not Limited Disease

2024-7-22

Comparison of the efficacy, safety and quality of life of pegylated liposomal doxorubicin-cyclophosphamide versus epirubicin-cyclophosphamide in patients with early stage HER2-negative breast cancer: A prospective, randomized, multicenter, Phase II study

2024-7-19

A Population-Based and Propensity Score-Matched Investigation of the Occurrence, Management, and Prognosis of Anal Mucinous Adenocarcinoma Patients

2024-6-27

Hypogammaglobulinemia and anti-CD20 therapy-induced acute thrombocytopenia: perhaps more than a coincidence?

2024-6-21

Geriatric Assessment Scale for Optimal Management of Gastric Cancer in Older Adults Who Underwent Gastrectomy: A Systematic Review

2024-6-13

Stereotactic Radiotherapy for penile metastasis: case report and systematic literature review

2024-5-18

A multicentre, randomized trial in adults with de novo Philadelphia-Chromosome positive acute lymphoblastic leukemia to assess the efficacy of ponatinib versus imatinib in combination with low-intensity chemotherapy, to compare end of therapy with indication for SCT versus TKI, blinatumomab and chemotherapy in optimal responders and to evaluate blinatumomab in suboptimal responders (GMALL-EVOLVE)

2024-5-16

Evaluation of the Impact of Adaptive Progressive Supervised Resistance Training on Strength and Quality of Life in Patients with Breast Cancer During Chemotherapy: The VALESCO Study

2024-5-7

Anaemia in hospitalized cancer patients: a retrospective study of two cohorts before and after the guideline update

2024-5-7

What do German Molecular Tumor Boards recommend in patients with PIK3CA mutated tumors? - Launch and first results from the German TEAM-D Transsectoral Molecular Tumor Board exchange platform Deutschland (TEAM-D) -

2024-5-7

Metastases affecting cranial nervous structures in male breast cancer: Two cases report.

2024-4-18

Association between metabolic reprogramming and immune regulation in digestive tract tumors

2024-4-18

High dose chemotherapy and autologous stem cell transplantation for salvage therapy of relapsed /refractory germ cell tumors; a single center experience

2024-4-5

Intradermal naked DNA vaccination by DNA tattooing for mounting tumor-specific immunity in stage IV melanoma patients: a phase I clinical trial

2024-4-5

Clinicopathologic Features And Efficacy Of Induction Chemotherapy In Nasopharyngeal Carcinoma: Real-World Experience

2024-4-2

Thoracic Oncology Highlights from the European Society for Medical Oncology Annual Meeting 2023 with Focus on Targeted Therapies

2024-3-25

Stability of end-of-life care wishes and gender-specific characteristics of outpatients with advanced cancer under palliative therapy. A prospective observational study.

2024-3-1

Aggressive B-Cell Lymphoma with Metastatic Spinal Cord Compression: Treat the Patient, Not the Disease

2024-3-1

Highlights of translational and molecular research presented at the European Society for Medical Oncology Annual Meeting 2023

2024-2-28

Spirituality in oncology: relations between spirituality, its facets and psychological and demographic factors in cancer patients in Germany

2024-2-7

Management of Patients undergoing CAR-T cell therapy in Germany

2024-1-10

Momelotinib bei Myelofibrose und Anämie

2024-1-1

Gastroesophageal Oncology Highlights from the European Society for Medical Oncology Annual Meeting 2023

2024-1-1

Colorectal Cancer Highlights from the European Society for Medical Oncology Annual Meeting 2023

2024-1-1

Pancreatic, Hepatic, and Biliary Tract Oncology Highlights from the European Society for Medical Oncology Annual Meeting 2023

2024-1-1

Society Bulletins

2024-1-1

Ibr+Ven: Vorteilhaftes Wirksamkeitsprofil bei CLL-Patient*

2024-1-1

Editing for Cure: in Conversation with Sylvie Lorenzen and Ralf-Dieter Hofheinz

2024-1-1

Society Bulletins

2024-1-1

PharmaNews

2024-1-1

PharmaNews

2024-1-1

Society Bulletins

2024-1-1

r/r LBCL: CAR-T-Zelltherapie im Behandlungsalltag

2024-1-1

PharmaNews

2024-1-1

Effektive Therapieoption: Pegcetacoplan bei PNH

2024-1-1

OnkoImmun 20

2024-1-1

PharmaNews

2024-1-1

Prelims

2024-1-1

Society Bulletins

2024-1-1

PharmaNews

2024-1-1

Psycho-Oncological Self-Help Groups in Bavaria: The Current Situation and Suggestions for Improvement

2024-1-1

Surgical Management and System Therapy of the Most Giant Known Malignant Metastatic Breast Phyllodes Tumor: A Case Report and Review of the Literature

2024-1-1

Society Bulletins

2024-1-1

Erstmals 3-Jahres-Daten bei biliären Karzinomen

2024-1-1

Society Bulletins

2024-1-1

Prioritization and Resource Allocation in the Context of the COVID-19 Pandemic: Recommendations for Colorectal and Pancreatic Cancer in Germany

2024-1-1

DKK 2024: Acalabrutinib im Praxis-Check

2024-1-1